Cancer Research Statistics and Treatment

Our screening does not flag Cancer Research Statistics and Treatment. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, PubMed, which is a positive signal.

Per our venue index, Cancer Research Statistics and Treatment appears in: DOAJ, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

Papers in Cancer Research Statistics and Treatment are cited about 1.1 times each within two years of publication, with an h-index of 29. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.

Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.

Free to publish — DOAJ lists no article processing charge (APC). So there is no fee for authors to publish in Cancer Research Statistics and Treatment. Fee policies change — confirm on the journal's own site before relying on it.

Submission to publication for Cancer Research Statistics and Treatment takes about ~15 wk — DOAJ self-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Cancer Research Statistics and Treatment.